• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Depression profile in malignancy patients attending otorhinolaryngology clinic.恶性肿瘤患者耳鼻喉科就诊的抑郁状况分析。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):537-541. doi: 10.1007/s00405-020-06289-w. Epub 2020 Aug 17.
2
The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital.PHQ-9 在精神病院重度抑郁症患者中的信度和效度。
BMC Psychiatry. 2020 Sep 29;20(1):474. doi: 10.1186/s12888-020-02885-6.
3
Validation of the PHQ-9 depression scale in Ethiopian cancer patients attending the oncology clinic at Tikur Anbessa specialized hospital.PHQ-9 抑郁量表在提克里蒂安贝萨专科医院肿瘤科就诊的埃塞俄比亚癌症患者中的验证。
BMC Psychiatry. 2020 Sep 10;20(1):446. doi: 10.1186/s12888-020-02850-3.
4
Screening for major depressive disorder in adults with glioma using the PHQ-9: a comparison of patient versus proxy reports.使用 PHQ-9 对胶质母细胞瘤成年患者进行重度抑郁症筛查:患者报告与代理报告的比较。
J Neurooncol. 2013 May;113(1):49-55. doi: 10.1007/s11060-013-1088-4. Epub 2013 Feb 24.
5
Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany.德国成年人中 DSM-IV-TR 重性抑郁障碍、自我报告确诊的抑郁症和当前抑郁症状的流行率及其相关因素。
J Affect Disord. 2016 Jan 15;190:167-177. doi: 10.1016/j.jad.2015.10.006. Epub 2015 Oct 24.
6
Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study.与居住在 12 个不同国家的 2 型糖尿病成人中重度抑郁症发病相关的因素:INTERPRET-DD 前瞻性研究结果。
Epidemiol Psychiatr Sci. 2020 Jun 2;29:e134. doi: 10.1017/S2045796020000438.
7
Patient Perception of Depressive Symptoms in Rheumatic Diseases: A Cross-sectional Survey.风湿性疾病患者对抑郁症状的感知:一项横断面调查。
J Clin Rheumatol. 2022 Jan 1;28(1):e18-e22. doi: 10.1097/RHU.0000000000001564.
8
Depression Screening in Diabetes Care to Improve Outcomes: Are We Meeting the Challenge?糖尿病护理中的抑郁筛查以改善预后:我们是否应对了挑战?
Diabetes Educ. 2016 Oct;42(5):646-51. doi: 10.1177/0145721716662917. Epub 2016 Aug 24.
9
Incremental decreases in quality-adjusted life years (QALY) associated with higher levels of depressive symptoms for U.S. Adults aged 65 years and older.65岁及以上美国成年人中,抑郁症状水平越高,与质量调整生命年(QALY)的增量减少相关。
Health Qual Life Outcomes. 2017 Jan 11;15(1):9. doi: 10.1186/s12955-016-0582-8.
10
Validity of brief screening questionnaires to detect depression in primary care in Ethiopia.在埃塞俄比亚的初级保健中,简短筛查问卷检测抑郁的有效性。
J Affect Disord. 2015 Nov 1;186:32-9. doi: 10.1016/j.jad.2015.07.015. Epub 2015 Jul 21.

本文引用的文献

1
The value of distinct depressive symptoms (PHQ-9) to differentiate depression severity in cancer survivors: An item response approach.不同抑郁症状(PHQ-9)对区分癌症幸存者抑郁严重程度的价值:一种项目反应方法。
Psychooncology. 2019 Nov;28(11):2240-2243. doi: 10.1002/pon.5192. Epub 2019 Aug 30.
2
Screening for depression in cancer patients using the PHQ-9: The accuracy of somatic compared to non-somatic items.使用 PHQ-9 对癌症患者进行抑郁筛查:躯体与非躯体项目的准确性比较。
J Affect Disord. 2019 Jul 1;254:74-81. doi: 10.1016/j.jad.2019.05.026. Epub 2019 May 13.
3
Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.头颈癌患者中抑郁症的风险:一项基于全国人口的研究。
Head Neck. 2018 Feb;40(2):312-323. doi: 10.1002/hed.24961. Epub 2017 Sep 30.
4
The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.医院焦虑抑郁量表(HADS)和9项患者健康问卷(PHQ - 9)作为癌症患者抑郁的筛查工具。
Cancer. 2017 Nov 1;123(21):4236-4243. doi: 10.1002/cncr.30846. Epub 2017 Jun 27.
5
Depression profile in cancer patients and patients without a chronic somatic disease.癌症患者和无慢性躯体疾病患者的抑郁状况。
Psychooncology. 2018 Jan;27(1):83-90. doi: 10.1002/pon.4465. Epub 2017 Jul 3.
6
Depression and survival in head and neck cancer patients.头颈癌患者的抑郁与生存情况
Oral Oncol. 2017 Feb;65:76-82. doi: 10.1016/j.oraloncology.2016.12.014. Epub 2017 Jan 1.
7
Assessing depression in a geriatric cancer population.评估老年癌症患者群体中的抑郁症。
Psychooncology. 2017 Oct;26(10):1484-1490. doi: 10.1002/pon.4160. Epub 2016 May 16.
8
Depression and Survival in Patients With Head and Neck Cancer: A Systematic Review.头颈癌患者的抑郁与生存:一项系统综述。
JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):284-8. doi: 10.1001/jamaoto.2015.3171.
9
The PHQ-9: validity of a brief depression severity measure.PHQ-9:一种简短抑郁严重程度测量工具的效度
J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

恶性肿瘤患者耳鼻喉科就诊的抑郁状况分析。

Depression profile in malignancy patients attending otorhinolaryngology clinic.

机构信息

Department of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, Mangalore, 575001, India.

Department of Psychiatry, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, Mangalore, 575001, India.

出版信息

Eur Arch Otorhinolaryngol. 2021 Feb;278(2):537-541. doi: 10.1007/s00405-020-06289-w. Epub 2020 Aug 17.

DOI:10.1007/s00405-020-06289-w
PMID:32804271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7826301/
Abstract

PURPOSE

Patients with malignancy quite often suffer from physical as well as psychological symptoms due to the shattering diagnosis, and prolonged, incapacitating management. The frequency of the depressive disorder in malignancy is around 8-40%. The present study aims at analysing the socio-demographic profile and magnitude of depressive disorders in patients with malignancy.

METHODS

A cross-sectional study was conducted in malignancy patients attending an Ear Nose Throat department using the PHQ-9 questionnaire.

RESULTS

Total PHQ-9 score ranged from 0 to 19; the mean score was 8.46. Major depressive disorder was seen in 4 (8%) cases, while other depressive disorder occurred in 22 (44%) cases. Mild severity of symptoms was noted in 15 (30%) of the patients. High statistical significance was noted between PHQ-9 score for MDD and other depressive disorder (p value < 0.001).

CONCLUSION

The profile of depressive disorders in malignancy varies; PHQ-9 can be used as a good tool for early detection.

摘要

目的

由于毁灭性的诊断和长期的致残治疗,患有恶性肿瘤的患者经常会出现身体和心理症状。恶性肿瘤中抑郁障碍的频率约为 8-40%。本研究旨在分析恶性肿瘤患者的社会人口统计学特征和抑郁障碍的严重程度。

方法

采用 PHQ-9 问卷对耳鼻喉科就诊的恶性肿瘤患者进行横断面研究。

结果

PHQ-9 总分范围为 0 至 19;平均得分为 8.46。4 例(8%)患者存在重度抑郁障碍,22 例(44%)患者存在其他抑郁障碍。15 例(30%)患者的症状严重程度较轻。重度抑郁障碍和其他抑郁障碍的 PHQ-9 评分之间存在显著统计学差异(p 值<0.001)。

结论

恶性肿瘤中抑郁障碍的表现形式不同;PHQ-9 可作为早期检测的良好工具。